发明名称 Selective HDAC3 inhibitors
摘要 Provided herein are HDAC3 inhibitors, as well as methods of treatment comprising administering these compounds to a subject in need thereof.
申请公布号 US9096549(B2) 申请公布日期 2015.08.04
申请号 US201414169732 申请日期 2014.01.31
申请人 ACETYLON PHARMACEUTICALS, INC. 发明人 van Duzer John H.;Mazitschek Ralph
分类号 C07D241/44;C07D215/54;C07D215/38;C07D217/26;C07D235/06;C07D471/04;C07D209/34;C07D231/56 主分类号 C07D241/44
代理机构 Lathrop & Gage LLP 代理人 Lathrop & Gage LLP ;Trinque Brian C.
主权项 1. A compound of Formula II:or a pharmaceutically acceptable salt thereof, whereinA is bicyclic heteroaryl or bicyclic heterocycloalkyl selected from the group consisting of R1 is halo; R3 is heterocycloalkyl, or C1-6-alkyl-heterocycloalkyl wherein the heterocycloalkyl or C1-6-alkyl-heterocycloalkyl groups are optionally substituted with C1-4-alkyl; R4 and R5 are each independently selected from H, C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, C3-6-cycloalkyl, C1-6-alkyl-C3-6-cycloalkyl, heterocycloalkyl, C1-6-alkyl-heterocycloalkyl, NR6R7, O—C1-6-alkyl-OR8, C1-6-alkyl-OR8, aryl, C1-6-alkyl-aryl, heteroaryl, C1-6-alkyl-heteroaryl, C(O)N(R6)-heteroaryl, C(O)N(R6)-heterocycloalkyl, C(O)N(R6)-aryl, C(O)—NR6R7, C(O) -heteroaryl, C(O)-heterocycloalkyl, C(O)-aryl, C(O)—C1-6-alkyl, CO2-heteroaryl, CO2-heterocycloalkyl, CO2-aryl, CO2-C1-6-alkyl, or C(O)—C1-6-alkyl-heterocycloalkyl, wherein the cycloalkyl, heterocycloalkyl, aryl, or heteroaryl groups are optionally substituted with C1-4-alkyl, CO2R8, C(O)R8, or C1-6-alkyl-OR8; R6 and R7 are each independently selected from H, C1-6-alkyl, C1-6-alkyl-OR8, CO2R8, or C1-C6-alkyl-aryl; and R8 is H or C1-6-alkyl.
地址 Boston MA US